The payer's Community Catalyst initiative includes 23 programs that involve collaborations with various community-based organizations and health centers. They tackle different types of social determinants of health issues, including food insecurity among seniors and the health needs of those in public housing.
An NGM Biopharmaceuticals drug candidate for the fatty liver disease NASH failed a Phase 2b study less than a year after the company reported positive results from an earlier mid-stage study. The biotech will now focus on programs in eye diseases and cancer that are partnered with Merck.
As the world of healthcare benefits becomes increasingly fragmented, Cedric Kovacs-Johnson sees a need for benefits administration to keep up. His startup, Flume, recently made its debut with $10 million in funding.
RPM is here to stay but if we do this wrong, the unintended consequence could be a lack of adoption, despite readiness by our government to pay for these services.
Fawad Butt, Author at MedCity News medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.